Monday, 26 October 2026 Updated 12 min ago
The News Engine
Latest
Health United States

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

Merck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend.

NPR reports: Merck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend.

Results are promising: The vaccine reduces recurrence and death alongside an immunotherapy drug.

This health story centres on the United States.

Why it matters

Health developments can affect patients, healthcare providers and public-health planning.

Key details

Location
United States · Americas
Reported by
NPR
First reported
Key names
European
Section
Health

Sources

This is an independent summary. Read the full, original reporting from the publisher:

Read the full story at NPR

Spotted an error? Request a correction · How this summary was produced

Related Stories